Bacher, Ulrike

[["dc.bibliographiccitation.firstpage","64"],["dc.bibliographiccitation.journal","Critical Reviews in Oncology/Hematology"],["dc.bibliographiccitation.lastpage","79"],["dc.bibliographiccitation.volume","126"],["dc.contributor.author","Shumilov, Evgenii"],["dc.contributor.author","Flach, Johanna"],["dc.contributor.author","Pabst, Thomas"],["dc.contributor.author","Fiedler, Martin"],["dc.contributor.author","Angelillo-Scherrer, Anne"],["dc.contributor.author","Trümper, Lorenz"],["dc.contributor.author","Joncourt, Raphael"],["dc.contributor.author","Kohlmann, Alexander"],["dc.contributor.author","Bacher, Ulrike"],["dc.date.accessioned","2020-12-10T14:23:20Z"],["dc.date.available","2020-12-10T14:23:20Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1016/j.critrevonc.2018.03.020"],["dc.identifier.issn","1040-8428"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/71901"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2233"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","Leukemia & Lymphoma"],["dc.bibliographiccitation.lastpage","2237"],["dc.bibliographiccitation.volume","59"],["dc.contributor.author","Bürki, Susanne"],["dc.contributor.author","Shumilov, Evgenii"],["dc.contributor.author","Bonadies, Nicolas"],["dc.contributor.author","Flach, Johanna"],["dc.contributor.author","Legros, Myriam"],["dc.contributor.author","Banz, Yara"],["dc.contributor.author","Oppliger-Leibundgut, Elisabeth"],["dc.contributor.author","Fiedler, Martin"],["dc.contributor.author","Angelillo-Scherrer, Anne"],["dc.contributor.author","Rovo, Alicia"],["dc.contributor.author","Bacher, Ulrike"],["dc.date.accessioned","2020-12-10T18:14:58Z"],["dc.date.available","2020-12-10T18:14:58Z"],["dc.date.issued","2017"],["dc.identifier.doi","10.1080/10428194.2017.1416367"],["dc.identifier.eissn","1029-2403"],["dc.identifier.issn","1042-8194"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/74691"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Coincidence of 5q deletion and the JAK2 V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","113"],["dc.bibliographiccitation.issue","11"],["dc.bibliographiccitation.journal","Blood Cancer Journal"],["dc.bibliographiccitation.volume","8"],["dc.contributor.author","Bacher, Ulrike"],["dc.contributor.author","Shumilov, Evgenii"],["dc.contributor.author","Flach, Johanna"],["dc.contributor.author","Porret, Naomi"],["dc.contributor.author","Joncourt, Raphael"],["dc.contributor.author","Wiedemann, Gertrud"],["dc.contributor.author","Fiedler, Martin"],["dc.contributor.author","Novak, Urban"],["dc.contributor.author","Amstutz, Ursula"],["dc.contributor.author","Pabst, Thomas"],["dc.date.accessioned","2019-07-09T11:50:49Z"],["dc.date.available","2019-07-09T11:50:49Z"],["dc.date.issued","2018"],["dc.description.abstract","Given the vast phenotypic and genetic heterogeneity of acute and chronic myeloid malignancies, hematologists have eagerly awaited the introduction of next-generation sequencing (NGS) into the routine diagnostic armamentarium to enable a more differentiated disease classification, risk stratification, and improved therapeutic decisions. At present, an increasing number of hematologic laboratories are in the process of integrating NGS procedures into the diagnostic algorithms of patients with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). Inevitably accompanying such developments, physicians and molecular biologists are facing unexpected challenges regarding the interpretation and implementation of molecular genetic results derived from NGS in myeloid malignancies. This article summarizes typical challenges that may arise in the context of NGS-based analyses at diagnosis and during follow-up of myeloid malignancies."],["dc.identifier.doi","10.1038/s41408-018-0148-6"],["dc.identifier.pmid","30420667"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/16009"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/59839"],["dc.language.iso","en"],["dc.notes.intern","Merged from goescholar"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.subject.ddc","610"],["dc.title","Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","508"],["dc.bibliographiccitation.issue","6"],["dc.bibliographiccitation.journal","Blood Reviews"],["dc.bibliographiccitation.lastpage","519"],["dc.bibliographiccitation.volume","32"],["dc.contributor.author","Shumilov, Evgenii"],["dc.contributor.author","Flach, Johanna"],["dc.contributor.author","Kohlmann, Alexander"],["dc.contributor.author","Banz, Yara"],["dc.contributor.author","Bonadies, Nicolas"],["dc.contributor.author","Fiedler, Martin"],["dc.contributor.author","Pabst, Thomas"],["dc.contributor.author","Bacher, Ulrike"],["dc.date.accessioned","2020-12-10T14:22:40Z"],["dc.date.available","2020-12-10T14:22:40Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1016/j.blre.2018.04.008"],["dc.identifier.issn","0268-960X"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/71689"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Current status and trends in the diagnostics of AML and MDS"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","319"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Hematological Oncology"],["dc.bibliographiccitation.lastpage","322"],["dc.bibliographiccitation.volume","37"],["dc.contributor.author","Shumilov, Evgenii"],["dc.contributor.author","Flach, Johanna"],["dc.contributor.author","Joncourt, Raphael"],["dc.contributor.author","Porret, Naomi"],["dc.contributor.author","Wiedemann, Gertrud"],["dc.contributor.author","Angelillo‐Scherrer, Anne"],["dc.contributor.author","Trümper, Lorenz"],["dc.contributor.author","Fiedler, Martin"],["dc.contributor.author","Jeker, Barbara"],["dc.contributor.author","Amstutz, Ursula"],["dc.contributor.author","Pabst, Thomas"],["dc.contributor.author","Bacher, Ulrike"],["dc.date.accessioned","2020-12-10T14:06:37Z"],["dc.date.available","2020-12-10T14:06:37Z"],["dc.date.issued","2019"],["dc.identifier.doi","10.1002/hon.v37.3"],["dc.identifier.eissn","1099-1069"],["dc.identifier.issn","0278-0232"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/69965"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]